Cargando…
Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials
BACKGROUND: Several trials have considered the safety and clinical benefits of colchicine as a treatment option for secondary prevention in patients with coronary atherosclerotic heart disease (CAD), but its safety and clinical benefits remain controversial. The purpose of this study was to explore...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512890/ https://www.ncbi.nlm.nih.gov/pubmed/36176989 http://dx.doi.org/10.3389/fcvm.2022.947959 |